Merck MRK

NYSE · Pharmaceutical Preparations · $353.7B
$137.78−3.90%Nov 18 close · Databento
Every report since 2023 →

Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.

2 stories have a settled next close so far (2 on the Wire). The record starts speaking at three.

The numbers

fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$353.7B
EV / True FCF33.6x
Revenue$65.0B +1.3%
True FCF (ex-SBC)$11.5B −31.7%
Rule of 4020.3%
True FCF Yield3.3%
EPS, diluted$7.28 +8.0%
Modern Valuation (EOD)
Market Cap$353.7B
Enterprise Value$388.4B
EV / True FCF33.65
EV / FCF31.42
EV / Gross Profit—
EV / EBIT—
EV / Sales5.97
P / E (GAAP)19.38
P / FCF28.62
P / Oper. CF21.47
P / Book6.72
Owner & Cash Yields
True FCF Yield3.3%
FCF Yield3.5%
Owner Earn. Yield4.6%
Earnings Yield5.2%
Shareholder Yield+3.5%
Buyback Yield1.4%
Dividend Yield2.38%
Dividend / sh$3.28
Payout Ratio45%
FCF / sh$5.01
EPS (diluted)$7.28
Compounder & Returns
Rule of 4020.3%
ROIC—
Cash ROIC (CROIC)14.2%
GP / Assets—
ROE34.7%
ROA13.3%
Gross Margin—
Oper. Margin—
Net Margin28.1%
FCF Margin19.0%
True FCF Margin17.8%
Quality & Dilution
Cash Conversion68%
Accrual Ratio+1.3%
SBC % of FCF6.6%
SBC % of Rev1.3%
Reinvest. Rate121%
Sales Growth Y/Y+1.3%
Sales 3Y CAGR+3.1%
EPS Growth Y/Y+8.0%
FCF Growth Y/Y−31.7%
FCF 3Y CAGR−5.6%
Share Change Y/Y−1.3%
Balance Sheet & Scale
Revenue (FY)$65.0B
Gross Profit (FY)—
Oper. Income (FY)—
GAAP Net Income$18.3B
True FCF (ex-SBC)$11.5B
Cash & Equiv$14.7B
Total Debt$49.3B
Net Cash (Debt)$-34.6B
Net Cash % MCap−9.8%
Debt / FCF (yrs)4.0y
Current Ratio1.542.47B sh
Price & Technicals (EOD)
Perf Week−6.39%
Perf Month−7.09%
Perf Quarter−7.52%
Perf Half Y+21.93%
Perf YTD+21.81%
SMA 20 Dist−5.41%$145.65
SMA 50 Dist−5.45%$145.72
SMA 100 Dist−1.96%$140.53
Window High−11.93%$156.45
Window Low+23.81%$111.28
RSI (14) · Vol37.233%v
Income Distribution & Cash Flow ConversionHow every dollar of MRK revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
REVENUE · 100%$65.0BGROSS PROFIT · 74.8%$48.6BCOST OF REV · 25.2%$16.4BOPER. INCOME · 74.8%$48.6BNET INCOME · 28.1%$18.3BTAX & OTHER · 46.7%$30.4B
Where Every $100 of Revenue Goes (FY2025)
Cost of Revenue (COGS)$16.4B ($25.2 / $100)
R&D Reinvestment$15.8B ($24.3 / $100)
SG&A & Other OpEx$10.7B ($16.5 / $100)
Tax & Non-Operating$30.4B ($46.7 / $100)
Net Profit Kept$18.3B ($0.0 / $100)
Earnings Quality: GAAP Profit → True Owner Cash (FY2025)
GAAP Net Income$18.3B (28.1% margin)
Operating Cash Flow (OCF)$16.5B(25.3% of rev)
Less: Capital Expenditures−$4.1B(6.3% of rev)
Standard Free Cash Flow (FCF)$12.4B(19.0% margin)
Less: Stock-Based Comp (SBC)−$820.0M(6.6% of FCF)
True FCF (Owner Cash ex-SBC)$11.5B(17.8% of rev)

Operating leverage — margins

GrossOperatingNet
0%40%80%28%FY21FY22FY23FY24FY25
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)FY2021FY2022FY2023FY2024FY2025YoY Δ4Y CAGRTrend
Income Statement
Cost of Revenue (COGS)$13.6B$17.4B$16.1B$15.2B$16.4B+7.8%+4.7%
Research & Development (R&D)$12.2B$13.5B$30.5B$17.9B$15.8B−12.0%+6.6%
Selling, General & Admin (SG&A)$9.6B$10.0B$10.5B$10.8B$10.7B−0.8%+2.7%
Interest Expense$806.0M$962.0M$1.1B$1.3B$1.4B+6.8%+13.9%
Income Tax Expense$1.5B$1.9B$1.5B$2.8B$2.8B+0.0%+16.5%
Diluted Shares2.54B2.54B2.55B2.54B2.51B−1.3%−0.3%
Balance Sheet
Cash & Equivalents$8.2B$12.8B$6.9B$13.3B$14.7B+10.3%+15.8%
Inventory$6.0B$5.9B$6.4B$6.1B$6.7B+9.0%+2.8%
Total Current Assets$30.3B$35.7B$32.2B$38.8B$43.5B+12.2%+9.5%
Total Assets$105.7B$109.2B$106.7B$117.1B$136.9B+16.9%+6.7%
Total Current Liabilities$23.9B$24.2B$25.7B$28.4B$28.3B−0.3%+4.4%
Total Debt (Short + Long Term)$33.1B$30.7B$35.1B$37.1B$49.3B+32.9%+10.5%
Stockholders' Equity$38.3B$46.1B$37.6B$46.4B$52.7B+13.6%+8.3%
Net Cash / (Net Debt)$-24.9B$-17.9B$-28.1B$-23.8B$-34.6B−45.6%—
Invested Capital$63.2B$64.0B$65.8B$70.2B$87.3B+24.4%+8.4%
Cash Flow & Capital Allocation
Depreciation & Amortization (D&A)$1.6B$1.8B$1.8B$2.1B$3.0B+44.7%+17.9%
Stock-Based Compensation (SBC)$479.0M$541.0M$645.0M$761.0M$820.0M+7.8%+14.4%
Capital Expenditures (CapEx)$4.4B$4.4B$3.9B$3.4B$4.1B+21.9%−1.9%
True FCF (ex-SBC Owner Cash)$8.2B$14.2B$8.5B$17.3B$11.5B−33.4%+8.9%
Share Repurchases (Buybacks)$840.0M$0$1.3B$1.3B$5.1B+289.3%+56.8%
Dividends Paid$6.6B$7.0B$7.4B$7.8B$8.2B+4.3%+5.5%

Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.

On the Wire

what MRK did at the next close after each story
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.